FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
The pure protein was dialyzed against PBS and stored at 80 C
The only human pharmacokinetic and pharmacodynamic trial data for CJC-1295 DAC comes from Teichman et al
Cancer Cell (2009) 16(3):18394
Treatment Recommendations for Hair Loss Caused by Ozempic If youre experiencing hair loss while taking Ozempic, its essential to consult your healthcare provider before making any changes to your treatment regimen
The Wegovy pill is an oral version licensed for weight loss, taken at 25 mg a day, and approved by the MHRA in June 2026